- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.11: 3 residues within 4Å:- Chain A: N.67, S.69, E.70
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.69
NAG.16: 3 residues within 4Å:- Chain B: N.67, S.69, E.70
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.69
NAG.20: 3 residues within 4Å:- Chain C: N.67, S.69, E.70
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.69
NAG.24: 3 residues within 4Å:- Chain D: N.67, S.69, E.70
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:S.69
NAG.28: 3 residues within 4Å:- Chain E: N.67, S.69, E.70
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:S.69
- 5 x R16: HEXADECANE(Non-covalent)
R16.12: 14 residues within 4Å:- Chain A: P.135, F.136, T.207, Y.210, G.211, L.214, L.215, I.270, Y.273, F.274, L.535, F.541, V.545, F.549
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:P.135, A:F.136, A:L.214, A:L.215, A:L.215, A:L.215, A:I.270, A:L.535, A:V.545, A:F.549
R16.17: 14 residues within 4Å:- Chain B: P.135, F.136, T.207, Y.210, G.211, L.214, L.215, I.270, Y.273, F.274, L.535, F.541, V.545, F.549
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:P.135, B:F.136, B:L.214, B:L.215, B:L.215, B:L.215, B:I.270, B:L.535, B:V.545, B:F.549
R16.21: 14 residues within 4Å:- Chain C: P.135, F.136, T.207, Y.210, G.211, L.214, L.215, I.270, Y.273, F.274, L.535, F.541, V.545, F.549
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:P.135, C:F.136, C:L.214, C:L.215, C:L.215, C:L.215, C:I.270, C:L.535, C:V.545, C:F.549
R16.25: 14 residues within 4Å:- Chain D: P.135, F.136, T.207, Y.210, G.211, L.214, L.215, I.270, Y.273, F.274, L.535, F.541, V.545, F.549
10 PLIP interactions:10 interactions with chain D- Hydrophobic interactions: D:P.135, D:F.136, D:L.214, D:L.215, D:L.215, D:L.215, D:I.270, D:L.535, D:V.545, D:F.549
R16.29: 14 residues within 4Å:- Chain E: P.135, F.136, T.207, Y.210, G.211, L.214, L.215, I.270, Y.273, F.274, L.535, F.541, V.545, F.549
10 PLIP interactions:10 interactions with chain E- Hydrophobic interactions: E:P.135, E:F.136, E:L.214, E:L.215, E:L.215, E:L.215, E:I.270, E:L.535, E:V.545, E:F.549
- 5 x 9Z9: (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en(Non-covalent)
9Z9.13: 9 residues within 4Å:- Chain A: W.315, C.316, W.318, F.319, L.320, L.518, M.521, A.522, V.525
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:W.315, A:F.319, A:F.319, A:F.319, A:A.522
9Z9.18: 9 residues within 4Å:- Chain B: W.315, C.316, W.318, F.319, L.320, L.518, M.521, A.522, V.525
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:W.315, B:F.319, B:F.319, B:F.319, B:A.522
9Z9.22: 9 residues within 4Å:- Chain C: W.315, C.316, W.318, F.319, L.320, L.518, M.521, A.522, V.525
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:W.315, C:F.319, C:F.319, C:F.319, C:A.522
9Z9.26: 9 residues within 4Å:- Chain D: W.315, C.316, W.318, F.319, L.320, L.518, M.521, A.522, V.525
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:W.315, D:F.319, D:F.319, D:F.319, D:A.522
9Z9.30: 9 residues within 4Å:- Chain E: W.315, C.316, W.318, F.319, L.320, L.518, M.521, A.522, V.525
5 PLIP interactions:5 interactions with chain E- Hydrophobic interactions: E:W.315, E:F.319, E:F.319, E:F.319, E:A.522
- 5 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.14: 14 residues within 4Å:- Chain A: A.223, L.226, L.227, L.230, R.517, L.520, S.524
- Chain E: L.283, V.286, I.290, Q.293, H.297, G.301, G.302
11 PLIP interactions:7 interactions with chain A, 4 interactions with chain E- Hydrophobic interactions: A:A.223, A:L.226, A:L.230, A:L.520, A:L.520, E:L.283, E:V.286, E:I.290
- Salt bridges: A:R.517, A:R.517
- Hydrogen bonds: E:Q.293
POV.15: 14 residues within 4Å:- Chain A: L.283, V.286, I.290, Q.293, H.297, G.301, G.302
- Chain B: A.223, L.226, L.227, L.230, R.517, L.520, S.524
11 PLIP interactions:7 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:A.223, B:L.226, B:L.230, B:L.520, B:L.520, A:L.283, A:V.286, A:I.290
- Salt bridges: B:R.517, B:R.517
- Hydrogen bonds: A:Q.293
POV.19: 14 residues within 4Å:- Chain B: L.283, V.286, I.290, Q.293, H.297, G.301, G.302
- Chain C: A.223, L.226, L.227, L.230, R.517, L.520, S.524
11 PLIP interactions:4 interactions with chain B, 7 interactions with chain C- Hydrophobic interactions: B:L.283, B:V.286, B:I.290, C:A.223, C:L.226, C:L.230, C:L.520, C:L.520
- Hydrogen bonds: B:Q.293
- Salt bridges: C:R.517, C:R.517
POV.23: 14 residues within 4Å:- Chain C: L.283, V.286, I.290, Q.293, H.297, G.301, G.302
- Chain D: A.223, L.226, L.227, L.230, R.517, L.520, S.524
11 PLIP interactions:7 interactions with chain D, 4 interactions with chain C- Hydrophobic interactions: D:A.223, D:L.226, D:L.230, D:L.520, D:L.520, C:L.283, C:V.286, C:I.290
- Salt bridges: D:R.517, D:R.517
- Hydrogen bonds: C:Q.293
POV.27: 14 residues within 4Å:- Chain D: L.283, V.286, I.290, Q.293, H.297, G.301, G.302
- Chain E: A.223, L.226, L.227, L.230, R.517, L.520, S.524
11 PLIP interactions:4 interactions with chain D, 7 interactions with chain E- Hydrophobic interactions: D:L.283, D:V.286, D:I.290, E:A.223, E:L.226, E:L.230, E:L.520, E:L.520
- Hydrogen bonds: D:Q.293
- Salt bridges: E:R.517, E:R.517
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Burke, S.M. et al., Structural mechanisms of alpha 7 nicotinic receptor allosteric modulation and activation. Cell (2024)
- Release Date
- 2024-02-21
- Peptides
- Neuronal acetylcholine receptor subunit alpha-7,Soluble cytochrome b562: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x R16: HEXADECANE(Non-covalent)
- 5 x 9Z9: (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en(Non-covalent)
- 5 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Burke, S.M. et al., Structural mechanisms of alpha 7 nicotinic receptor allosteric modulation and activation. Cell (2024)
- Release Date
- 2024-02-21
- Peptides
- Neuronal acetylcholine receptor subunit alpha-7,Soluble cytochrome b562: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.